Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.13 USD | -2.06% | +0.99% | +5.63% |
Mar. 18 | Fulcrum Therapeutics Appoints Patrick Horn as Chief Medical Officer | MT |
Mar. 18 | Fulcrum Therapeutics, Inc. Announces Executive Changes | CI |
Financials (USD)
Sales 2024 * | 1.68M | Sales 2025 * | 11.67M | Capitalization | 443M |
---|---|---|---|---|---|
Net income 2024 * | -113M | Net income 2025 * | -117M | EV / Sales 2024 * | 229 x |
Net cash position 2024 * | 58.66M | Net Debt 2025 * | 119M | EV / Sales 2025 * | 48.1 x |
P/E ratio 2024 * |
-4.15
x | P/E ratio 2025 * |
-4.34
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.62% |
Latest transcript on Fulcrum Therapeutics, Inc.
1 day | -2.06% | ||
1 week | +0.99% | ||
Current month | -24.47% | ||
1 month | -24.39% | ||
3 months | +1.86% | ||
6 months | +118.04% | ||
Current year | +5.63% |
Managers | Title | Age | Since |
---|---|---|---|
Alex Sapir
CEO | Chief Executive Officer | 57 | 23-06-30 |
Alan Musso
DFI | Director of Finance/CFO | 61 | 23-08-06 |
Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Geraghty
BRD | Director/Board Member | 70 | 16-07-18 |
Director/Board Member | 70 | 16-11-30 | |
James Collins
BRD | Director/Board Member | 58 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% | ||
0.00% | 9 M€ | +5.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 7.13 | -2.06% | 536,492 |
24-04-24 | 7.28 | -2.15% | 348,054 |
24-04-23 | 7.44 | +2.62% | 510,498 |
24-04-22 | 7.25 | +5.99% | 607,170 |
24-04-19 | 6.84 | -3.12% | 555,199 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.63% | 452M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- FULC Stock